New Zealand markets closed

Amylyx Pharmaceuticals, Inc. (AMLX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.8800-0.0700 (-3.59%)
At close: 04:00PM EDT
1.8700 -0.01 (-0.53%)
After hours: 07:31PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5565
Avg. Estimate-0.01-0.7-1.6-0.77
Low estimate-0.38-1.05-2.65-2.05
High estimate0.32-0.23-0.250.92
Year ago EPS0.020.310.7-1.6
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5355
Avg. Estimate98.35M12.63M106.13M331.98M
Low estimate72M250k72.5MN/A
High estimate114.32M20.4M132.6M572.65M
Year ago sales71.43M98.22M380.79M106.13M
Sales growth (year/est)37.70%-87.10%-72.10%212.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.240.10.430.23
Actual EPS0.020.310.30.07
Difference0.260.21-0.13-0.16
Surprise %108.30%210.00%-30.20%-69.60%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.01-0.7-1.6-0.77
7 days ago-0.01-0.7-1.6-0.77
30 days ago0-0.5-1.35-0.87
60 days ago0.260.341.541.86
90 days ago0.280.381.652.19
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAMLXIndustrySector(s)S&P 500
Current qtr.-150.00%N/AN/AN/A
Next qtr.-325.80%N/AN/AN/A
Current year-328.60%N/AN/AN/A
Next year51.90%N/AN/AN/A
Next 5 years (per annum)65.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A